Current Report Filing (8-k)
2017年5月13日 - 5:08AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
May 12, 2017
Date
of Report (Date of earliest event reported)
Tocagen Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-38052
|
|
26-1243872
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
3030 Bunker Hill Street, Suite 230
San Diego, California
|
|
92109
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(858) 412-8400
Check the appropriate box below
if the Form
8-K
filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to
Rule 13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined
in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (§ 240.12b2 of this chapter).
Emerging growth company ☒
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☒
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
Retirement of Executive Vice President
Thomas E. Darcy, our former executive vice president, retired from Tocagen Inc., effective as of May 12, 2017. He remains a member of the Companys
board of directors.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Tocagen Inc.
|
|
|
|
|
Dated: May 12, 2017
|
|
|
|
By:
|
|
/s/ Mark Foletta
|
|
|
|
|
|
|
Mark Foletta
|
|
|
|
|
|
|
Chief Financial Officer
|
Tocagen (NASDAQ:TOCA)
過去 株価チャート
から 6 2024 まで 7 2024
Tocagen (NASDAQ:TOCA)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about Tocagen Inc (ナスダック市場): 0 recent articles
その他のTocagen Incニュース記事